News

News

Your Current Position: News

22

2014-01

【Company News】 Six kind of sterile bulk drug product(such as ceftriaxone sodium), are approved by the national GMP certification
17

2013-04

【Company News】 A production technology of the company was granted national invention patent
03

2013-04

【Company News】 April 3, 2013, a production technology of the company was granted national invention patent and certificate number：ZL20111018648
27

2012-12

【Company News】 Piperacillin, the major product of the company, was certified by KFDA
18

2012-09

【Company News】 Piperacillin, the major product of the company, was certified by EDQM
14

2011-03

【Company News】 March 24,2011,Piperacillin, the major product of the company, was certified by FDA
29

2019-05

【Industry News】 Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA
24

2018-02

【Industry News】 Shandong Ruiying Runze Pharmaceutical Group participated in the 78th National Pharmaceutical Trade Fair, and launched a grand la
16

2015-11

【Industry News】 Seek business opportunities together and seek common development
12

2015-09

【Industry News】 Ruiying Pioneer Fluoxetine and Potassium Clavulanate Successfully Passed on-site Inspection

First <Previous 1 2 3 4 5 6 7 8 9 ... Next> End